Last week, Quebec became the first governing medical body in Canada to publicly fund medical psilocybin-assisted psychotherapy, with advocates hoping The...
Also a peek at their plans for the year ahead. The post How 5 Psychedelics Companies Fared in 2022 appeared first on Green Market Report.
Be the nerdiest person at your holiday parties this year by dispelling one of the most persistent psychedelic history myths! The post The Myth of the...
The article Top 5 Psychedelic Milestones of 2022 was originally published on Microdose. As we turn the final pages of 2022, it’s important to take a...
It is currently as good a time as ever for long-term investors to buy stocks. With that in mind, I decided to look for seven cheap...
As psychedelic-assisted therapies near FDA approval, questions remain about cost, who's paying, and how much it saves patients and insurers in the long...
The article Gilgamesh Pharmaceuticals Raises $39 Million in Series B Financing was originally published on Microdose. Gilgamesh Pharmaceuticals has announced...
It has been quite a year for the psychedelics industry. We’ve experienced our fair share of ups and downs, opportunities and uncertainties, and a great...
Drug overdoses in the United States have risen sharply in the last two decades. Nearly 92,000 people died from overdoses of illegal drugs and prescription...
The article PharmaTher Receives FDA Orphan Drug Designation for Ketamine was originally published on Microdose. For more on Pharmather, check out PharmaTher...